{"count": 87, "results": [{"_id": "37033509", "pmid": 37033509, "pmcid": "PMC10078117", "title": "Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority Trial", "journal": "Cureus", "authors": ["Dash A", "Meher BR", "Padhy BM", "Mohanty RR", "Tripathy A"], "date": "2023-03-07T00:00:00Z", "doi": "10.7759/cureus.35865", "meta_date_publication": "2023 Mar", "meta_volume": "15", "meta_issue": "3", "meta_pages": "e35865", "score": 50281.223, "text_hl": "Safety analysis of our study showed that @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headache@@@ was the most frequently reported adverse effect in the @CHEMICAL_azilsartan @CHEMICAL_MESH:C521273 @@@azilsartan@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ group (12%). ", "citations": {"NLM": "Dash A, Meher BR, Padhy BM, Mohanty RR, Tripathy A. Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority Trial Cureus. 2023 Mar;15(3):e35865. PMID: 37033509", "BibTeX": "@article{37033509, title={Comparison of Efficacy and Safety of Azilsartan and Amlodipine Combination Versus Telmisartan and Amlodipine Combination in Hypertensive Patients: A Non-inferiority Trial}, author={Dash A and Meher BR and Padhy BM and Mohanty RR and Tripathy A}, journal={Cureus}, volume={15}, number={3}, pages={e35865}}"}}, {"_id": "36287359", "pmid": 36287359, "title": "Evaluation of the Safety and Efficacy of Dual Therapy Perindopril/Amlodipine in the Management of Hypertension. A Systematic Review and Meta-Analysis.", "journal": "High Blood Press Cardiovasc Prev", "authors": ["Mostafa S", "Shabana H", "Khalil F", "Mancy IME", "Zedan HA", "Elmoursi A", "Ramadan IG", "Mohamed SED", "Kassem A", "Kamel IS"], "date": "2022-11-01T00:00:00Z", "doi": "10.1007/s40292-022-00544-3", "meta_date_publication": "2022 Nov", "meta_volume": "29", "meta_issue": "6", "meta_pages": "565-576", "score": 50247.918, "text_hl": "Evaluation of the Safety and Efficacy of Dual Therapy @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@Perindopril@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ in the Management of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertension@@@. ", "citations": {"NLM": "Mostafa S, Shabana H, Khalil F, Mancy IME, Zedan HA, Elmoursi A, Ramadan IG, Mohamed SED, Kassem A, Kamel IS. Evaluation of the Safety and Efficacy of Dual Therapy Perindopril/Amlodipine in the Management of Hypertension. A Systematic Review and Meta-Analysis. High Blood Press Cardiovasc Prev. 2022 Nov;29(6):565-576. PMID: 36287359", "BibTeX": "@article{36287359, title={Evaluation of the Safety and Efficacy of Dual Therapy Perindopril/Amlodipine in the Management of Hypertension. A Systematic Review and Meta-Analysis.}, author={Mostafa S and Shabana H and Khalil F and Mancy IME and Zedan HA and Elmoursi A and Ramadan IG and Mohamed SED and Kassem A and Kamel IS}, journal={High Blood Press Cardiovasc Prev}, volume={29}, number={6}, pages={565-576}}"}}, {"_id": "39551851", "pmid": 39551851, "title": "Efficacy and Safety of Yangxue Qingnao Pills Combined with Amlodipine in Treatment of Hypertensive Patients with Blood Deficiency and Gan-Yang Hyperactivity: A Multicenter, Randomized Controlled Trial.", "journal": "Chin J Integr Med", "authors": ["Wang F", "Gao HQ", "Lyu Z", "Wang XM", "Han H", "Wang YX", "Lu F", "Dong B", "Pu J", "Liu F", "Zu XG", "Liu HB", "Yang L", "Zhang SY", "Yan YM", "Wang XL", "Chen JH", "Liu M", "Yang YM", "Li XY"], "date": "2024-11-18T00:00:00Z", "doi": "10.1007/s11655-024-4001-4", "meta_date_publication": "2024 Nov 18", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50247.203, "text_hl": "CONCLUSIONS: Combination therapy of YXQNP with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ significantly improved symptoms such as @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@ and @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headache@@@, reduced blood pressure variability, and showed a trend toward lowering urinary microalbumin in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Wang F, Gao HQ, Lyu Z, Wang XM, Han H, Wang YX, Lu F, Dong B, Pu J, Liu F, Zu XG, Liu HB, Yang L, Zhang SY, Yan YM, Wang XL, Chen JH, Liu M, Yang YM, Li XY. Efficacy and Safety of Yangxue Qingnao Pills Combined with Amlodipine in Treatment of Hypertensive Patients with Blood Deficiency and Gan-Yang Hyperactivity: A Multicenter, Randomized Controlled Trial. Chin J Integr Med. 2024 Nov 18;():. PMID: 39551851", "BibTeX": "@article{39551851, title={Efficacy and Safety of Yangxue Qingnao Pills Combined with Amlodipine in Treatment of Hypertensive Patients with Blood Deficiency and Gan-Yang Hyperactivity: A Multicenter, Randomized Controlled Trial.}, author={Wang F and Gao HQ and Lyu Z and Wang XM and Han H and Wang YX and Lu F and Dong B and Pu J and Liu F and Zu XG and Liu HB and Yang L and Zhang SY and Yan YM and Wang XL and Chen JH and Liu M and Yang YM and Li XY}, journal={Chin J Integr Med}}"}}, {"_id": "37789979", "pmid": 37789979, "pmcid": "PMC10545146", "title": "Guillain-Barre Syndrome Complicated by Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome", "journal": "Eur J Case Rep Intern Med", "authors": ["Kobayashi H", "Hoshina Y", "Higa H", "Watari T"], "date": "2023-08-16T00:00:00Z", "doi": "10.12890/2023_003949", "meta_date_publication": "2023", "meta_volume": "10", "meta_issue": "10", "meta_pages": "003949", "score": 50243.754, "text_hl": "@DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertension@@@ was controlled with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ (5 mg). Her @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headaches@@@ and blood pressure stabilised in 9 days, and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ was discontinued. ", "citations": {"NLM": "Kobayashi H, Hoshina Y, Higa H, Watari T. Guillain-Barre Syndrome Complicated by Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome Eur J Case Rep Intern Med. 2023;10(10):003949. PMID: 37789979", "BibTeX": "@article{37789979, title={Guillain-Barre Syndrome Complicated by Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome}, author={Kobayashi H and Hoshina Y and Higa H and Watari T}, journal={Eur J Case Rep Intern Med}, volume={10}, number={10}, pages={003949}}"}}, {"_id": "33108624", "pmid": 33108624, "title": "Telmisartan Plus S-Amlodipine Single-Pill Combination Therapy is Safe and Effective in Patients with Hypertension from Large-Scale Nationwide Surveillance Data in Korea (NOVEL) Study.", "journal": "Adv Ther", "authors": ["Jo SH", "Park SJ", "Hong GR", "Kim SW", "Park CG"], "date": "2021-01-01T00:00:00Z", "doi": "10.1007/s12325-020-01533-5", "meta_date_publication": "2021 Jan", "meta_volume": "38", "meta_issue": "1", "meta_pages": "304-315", "score": 50242.773, "text_hl": "@DISEASE_Dizziness @DISEASE_MESH:D004244 @@@Dizziness@@@ and @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headache@@@ were most common (134 [0.30%] and 81 [0.18%]) among all adverse events. ", "citations": {"NLM": "Jo SH, Park SJ, Hong GR, Kim SW, Park CG. Telmisartan Plus S-Amlodipine Single-Pill Combination Therapy is Safe and Effective in Patients with Hypertension from Large-Scale Nationwide Surveillance Data in Korea (NOVEL) Study. Adv Ther. 2021 Jan;38(1):304-315. PMID: 33108624", "BibTeX": "@article{33108624, title={Telmisartan Plus S-Amlodipine Single-Pill Combination Therapy is Safe and Effective in Patients with Hypertension from Large-Scale Nationwide Surveillance Data in Korea (NOVEL) Study.}, author={Jo SH and Park SJ and Hong GR and Kim SW and Park CG}, journal={Adv Ther}, volume={38}, number={1}, pages={304-315}}"}}, {"_id": "37960797", "pmid": 37960797, "pmcid": "PMC10637500", "title": "Posterior reversible encephalopathy syndrome in a patient with late postpartum eclampsia", "journal": "Medicine (Baltimore)", "authors": ["Zhu M", "Huang H"], "date": "2023-11-10T00:00:00Z", "doi": "10.1097/MD.0000000000035867", "meta_date_publication": "2023 Nov 10", "meta_volume": "102", "meta_issue": "45", "meta_pages": "e35867", "score": 50241.977, "text_hl": "On day 2, the @SPECIES_9606 @@@patient@@@ became conscious, @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headache@@@ and vision improved. ", "citations": {"NLM": "Zhu M, Huang H. Posterior reversible encephalopathy syndrome in a patient with late postpartum eclampsia Medicine (Baltimore). 2023 Nov 10;102(45):e35867. PMID: 37960797", "BibTeX": "@article{37960797, title={Posterior reversible encephalopathy syndrome in a patient with late postpartum eclampsia}, author={Zhu M and Huang H}, journal={Medicine (Baltimore)}, volume={102}, number={45}, pages={e35867}}"}}, {"_id": "31373174", "pmid": 31373174, "pmcid": "PMC7187173", "title": "Pharmacokinetic and Safety Profiles of a Fixed-Dose Combination of Amlodipine, Valsartan, and Atorvastatin: A 3-Period Replicate Crossover Study", "journal": "Clin Pharmacol Drug Dev", "authors": ["Kim S", "Ko JW", "Kim JR"], "date": "2020-04-01T00:00:00Z", "doi": "10.1002/cpdd.727", "meta_date_publication": "2020 Apr", "meta_volume": "9", "meta_issue": "3", "meta_pages": "386-394", "score": 50241.965, "text_hl": "According to previous studies, @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headache@@@ was a common AE following administration of the @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @CHEMICAL_Valsartan @CHEMICAL_MESH:D000068756 @@@valsartan@@@ combination,27 and increased @GENE_CMPK1 @GENE_51727 @@@CK@@@ was one of the well-recognized AEs of atorvastatin.28 There was no significant difference in terms of safety between the 2 interventions.", "citations": {"NLM": "Kim S, Ko JW, Kim JR. Pharmacokinetic and Safety Profiles of a Fixed-Dose Combination of Amlodipine, Valsartan, and Atorvastatin: A 3-Period Replicate Crossover Study Clin Pharmacol Drug Dev. 2020 Apr;9(3):386-394. PMID: 31373174", "BibTeX": "@article{31373174, title={Pharmacokinetic and Safety Profiles of a Fixed-Dose Combination of Amlodipine, Valsartan, and Atorvastatin: A 3-Period Replicate Crossover Study}, author={Kim S and Ko JW and Kim JR}, journal={Clin Pharmacol Drug Dev}, volume={9}, number={3}, pages={386-394}}"}}, {"_id": "34464373", "pmid": 34464373, "title": "Difficulties in the diagnostics of chronic hyponatremia based on the case study of a 66-year old female patient during antihypertensive therapy.", "journal": "Pol Merkur Lekarski", "authors": ["Winiarska K", "Taborek M", "Czerwieńska B", "Więcek A", "Adamczak M"], "date": "2021-08-16T00:00:00Z", "meta_date_publication": "2021 Aug 16", "meta_volume": "49", "meta_issue": "292", "meta_pages": "303-305", "score": 50233.465, "text_hl": "For about two years the @SPECIES_9606 @@@patient@@@ had suffered from the following symptoms: severe @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headaches@@@, @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@, episodic mental @DISEASE_Confusion @DISEASE_MESH:D003221 @@@confusions@@@, stomachaches, and @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@. ", "citations": {"NLM": "Winiarska K, Taborek M, Czerwieńska B, Więcek A, Adamczak M. Difficulties in the diagnostics of chronic hyponatremia based on the case study of a 66-year old female patient during antihypertensive therapy. Pol Merkur Lekarski. 2021 Aug 16;49(292):303-305. PMID: 34464373", "BibTeX": "@article{34464373, title={Difficulties in the diagnostics of chronic hyponatremia based on the case study of a 66-year old female patient during antihypertensive therapy.}, author={Winiarska K and Taborek M and Czerwieńska B and Więcek A and Adamczak M}, journal={Pol Merkur Lekarski}, volume={49}, number={292}, pages={303-305}}"}}, {"_id": "33228516", "pmid": 33228516, "title": "[Comorbidity of arterial hyperten-sion and tension-type headache].", "journal": "Kardiologiia", "authors": ["Petrova MM", "Moskaleva PV", "Shnayder NA", "Nasyrova RF"], "date": "2020-11-12T00:00:00Z", "doi": "10.18087/cardio.2020.10.n1363", "meta_date_publication": "2020 Nov 12", "meta_volume": "60", "meta_issue": "10", "meta_pages": "132-140", "score": 50233.383, "text_hl": "Triplixam is a fixed triple combination of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@/@CHEMICAL_Indapamide @CHEMICAL_MESH:D007190 @@@indapamide@@@/@CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@, and its individual components have low and medium risk for development of @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headache@@@.", "citations": {"NLM": "Petrova MM, Moskaleva PV, Shnayder NA, Nasyrova RF. [Comorbidity of arterial hyperten-sion and tension-type headache]. Kardiologiia. 2020 Nov 12;60(10):132-140. PMID: 33228516", "BibTeX": "@article{33228516, title={[Comorbidity of arterial hyperten-sion and tension-type headache].}, author={Petrova MM and Moskaleva PV and Shnayder NA and Nasyrova RF}, journal={Kardiologiia}, volume={60}, number={10}, pages={132-140}}"}}, {"_id": "28387969", "pmid": 28387969, "title": "Amlodipine: The double edged sword.", "journal": "J Paediatr Child Health", "authors": ["Rabah F", "El-Naggari M", "Al-Nabhani D"], "date": "2017-06-01T00:00:00Z", "doi": "10.1111/jpc.13517", "meta_date_publication": "2017 Jun", "meta_volume": "53", "meta_issue": "6", "meta_pages": "540-542", "score": 50071.258, "text_hl": "This is mainly due to its long half-life making it easy to use as a single daily dose. @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ is associated with common side effects like @DISEASE_Flushing @DISEASE_MESH:D005483 @@@flushing@@@, @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headache@@@ and @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@. ", "citations": {"NLM": "Rabah F, El-Naggari M, Al-Nabhani D. Amlodipine: The double edged sword. J Paediatr Child Health. 2017 Jun;53(6):540-542. PMID: 28387969", "BibTeX": "@article{28387969, title={Amlodipine: The double edged sword.}, author={Rabah F and El-Naggari M and Al-Nabhani D}, journal={J Paediatr Child Health}, volume={53}, number={6}, pages={540-542}}"}}]}